{"id":"NCT02311881","sponsor":"GlaxoSmithKline","briefTitle":"A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis","officialTitle":"An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-01","primaryCompletion":"2016-02","completion":"2016-02","firstPosted":"2014-12-09","resultsPosted":"2017-04-07","lastUpdate":"2017-04-07"},"enrollment":960,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Paracetamol 1000 mg SR tablets","otherNames":[]},{"type":"DRUG","name":"Paracetamol 665 mg SR tablets","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Paracetamol 2000 mg twice daily (BID)","type":"EXPERIMENTAL"},{"label":"Paracetamol 1330 mg thrice daily (TID)","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to determine whether paracetamol 1000 mg sustained-release (SR) tablets administered orally, twice daily are effective and safe in the treatment of patients with osteoarthritis of the knee or hip.","primaryOutcome":{"measure":"Time-weighted Mean Change From Baseline in Western Ontario McMaster (WOMAC) Pain Through Week 12 of Treatment","timeFrame":"Baseline up to week 12","effectByArm":[{"arm":"Paracetamol 2000 mg Twice Daily (BID)","deltaMin":-28.25,"sd":1.697},{"arm":"Paracetamol 1330 mg Thrice Daily (TID)","deltaMin":-25.89,"sd":1.714},{"arm":"Placebo","deltaMin":-25.74,"sd":1.713}],"pValues":[{"comp":"OG000 vs OG002","p":"0.1626"},{"comp":"OG000 vs OG001","p":null},{"comp":"OG001 vs OG002","p":"0.9352"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":56,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":234},"commonTop":["NAUSEA","DIARRHOEA","HEADACHE","ALANINE AMINOTRANSFERASE INCREASED","UPPER RESPIRATORY TRACT INFECTION"]}}